Tag | Content |
---|
EnhancerAtlas ID | HS108-38327 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr7:142992400-142994450 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr7:142994298-142994310 | GCTATTTATAGA | - | 6.37 | MEF2B | MA0660.1 | chr7:142994298-142994310 | GCTATTTATAGA | - | 6.27 | Myod1 | MA0499.1 | chr7:142992940-142992953 | AGCAACAGCTGCT | - | 6.59 | NR2C2 | MA0504.1 | chr7:142993010-142993025 | AAGGGGCAAAGGGCA | + | 6.06 | Stat6 | MA0520.1 | chr7:142992983-142992998 | GCTTTCCTGAGAAGT | + | 6.42 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_13158 | chr7:142992469-142993242 | CD34_Primary_RO01480 | SE_13158 | chr7:142993260-142994027 | CD34_Primary_RO01480 | SE_14285 | chr7:142992405-142994250 | CD34_Primary_RO01549 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH07I143295 | chr7 | 142992380 | 142994440 |
|
Enhancer Sequence | ATGAGCTACG GCACCTGGCT GGGAAAGTAT TCTTAACATT TGTGTAATCA CAAGTCATAG 60 GGTAGATTGT TTGTGGACCA GATTTCTAGA AATTGTAAAC ATTTTCATTA TGGGCTGTTC 120 GTCATTAACC TCAGTTACTG TACTGCACAA CTGACTTTGT GACCTTTAGG GTTTCTATTT 180 TGCAATCAAT AATGGCCTAT TTGTAGATTC ATATTCACTC TTTATTTTGA TTCCAGAATA 240 GTAGAACTTT CTTCAACTTG CTTTGAGGTT GTCAGTGGTG AAATTAAAAT TGCTAGGAGA 300 TTCACTTTGA TCTGTTGGGA TAGAGGATCT TTGTTTTCCA TTCAGCATTG TCTGTAGTCT 360 TCATTTCTCT TTCTTAGCTG CCCTCCTTCT GTGAGAGTAA TTATGTATTT ACTATATTTT 420 TGGCAAGGCC AGTTTCATCC ACAGGTACCT GGGTGTTGTC CTTTACATGC TATTTTTGCC 480 AGCTTCCCCC TTGTAGCATA TGCAATGTAG TTAAATCCAC CCTTGCTTCA AAGCCATGGC 540 AGCAACAGCT GCTTCAGTCA TCAAGTATTC AGGTAGTTTA TATGCTTTCC TGAGAAGTCT 600 GCTGGGCATA AAGGGGCAAA GGGCAGGGTA CCAGCCATAA TTCCTACAGA AGGTCACTTA 660 ACAAAATGTG CAGTGTGTGT GTTTTCTTAG AGGTTTTGGT CTAGCCATGT CTTTTACTAG 720 AAATCTATTA TGTCATGGTT TTTCAAGTTG TATGCAGCTG ATAAAGGATC TTACATGTCT 780 AATAGTTAAA GATAAAATAC TGAGTCACTA AGTCAACTAT ATATACTGCT GTTTTCTCAG 840 AGACTGTCAG ATTTGGTGAG TTTATGAGCT CACTTCATAA ATAGCATTTC CATTTATGGT 900 AAGCCTGATG CATATTCAGT GACCTATTGG ATTCTAATTC TTTGGTTGAA TTGCTCTGTA 960 ACTGGAATTG CAGTAGAGTT GAACTTCAAG CACCTTATAA TGGGGGACTA TGTGAGCTGC 1020 CACAGATTTT AAAGATCAGA TGAGGGAGTT TTGACATCAG CATAAAAGGA AGTGTGTCCT 1080 CTTATATTCC TAACGACCAA ACAAGATTAG AGAAAAAATC TTCTGTCATA GCTAAGAAGA 1140 AGAAGCGCCT AGGTAGATAT GATCAGAAGG ATAAGTGGAG GAGGCAGAAC TTAAGCTGGC 1200 CTTGAAGGAT AGAAGTTACT GAAGCAGAGA GGAGTGGTGA AGCCACCCTA GGCAGGGAGA 1260 ACAGTATGTG GACAAGAAAT GTGTGTGTTA TAAACCAGGT AGTTGCAATG GGTGTCATAA 1320 TTTGGTACAC TGGGCATCTG CACAGAATGC TCTCTTCCTG GTGGGATCTC CCTAGAGAGT 1380 CAACTCGTTT ATCATATAGC TATTTGGCAA GCAAAGAAAC AGAACCAAAA AAAAAAAAAA 1440 GATCCTTTTT TCTTTCCCTA TCAAATCTTT CTTACTTAAG AGAGGAATTC CATTTAAAAA 1500 CAGGAAATAG TATAATTAGT CTTAGAGACT CCTCTTCCCC TGATAGTGCT GCAGTGAACA 1560 TGGGTATTCT CACTGCCCAG ATGTTTTCAC TTTTCTCTTT GTTATTAAGT TTTTATTGCA 1620 TCTACTTCAT GAGGTTACTA GTTCTAGAAT TATGATTTAC CCTATGTTAG GAAACGTACT 1680 CTTCAAAGTG GAAATTTCCT TTTACCATGT GGTATTGTTT TTTTAGCTTG CATTTGGGTC 1740 ACAAACTGCT TTGAAAATGT AAGGACAAGC TATGGGTTAT CCCTGGAAAA TGCAGCTGCC 1800 CATATAATTT AGCATATAAT TTCAGAGGGT TCACAAGTTA CTCTCTTCAC ATGTCCCCCA 1860 ACCCCTAGCC AAAAATACAC TTAGGAGTTA AGAACCCTGC TATTTATAGA AGTACTGTAA 1920 TTTTATCAAA AACAAATCTG CAGATCCTAT TTTAAGCTAT GCTACTTGTA GAAAAATTCC 1980 TCCAAATGTC TAATCCCCAT TTATTGAATG GTTTAGTCTT ACTAAGTTTG GTTACAAAGT 2040 GCGTGTATTC 2050
|